Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)
This study has been completed.
First Posted: April 4, 2006
Last Update Posted: September 14, 2006
Chiron s.r.l. Beijing Representative Office
Information provided by: